Literature DB >> 2954874

Human T cell clones reactive with hepatitis B virus (HBV) surface antigen from a HBV vaccine recipient.

A Nonomura, G Ohta.   

Abstract

Five T-cell clones reactive with HBsAg were obtained from peripheral blood lymphocytes of a HBV vaccine recipient by means of in vitro stimulation of lymphocytes for 5 days by HBsAg and subsequent re-culture of lymphocytes with HBsAg, feeder cells and T cell growth factor (TCGF) for 6 days, followed by the limiting dilution method. Clones, and subclones derived from one original clone showed a specific proliferative response to HBsAg in the presence of autologous feeder cells but not to unrelated antigens, such as influenza virus antigens, herpes simplex antigens, toxoplasma antigens, and PPD. All clones were found to have a surface marker of helper/inducer phenotype, Leu 1+, Leu 2a-, and Leu 3a+, detected by an indirect immunofluorescence method. These clones, however, did not show a substantial helper effect for in vitro anti-HBs production by autologous B cells. This suggests that the mechanism of the helper effect by specific T-cell clones is implicated, and functions of such clones other than specific helper effect on antibody-producing B cells must be considered.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2954874     DOI: 10.1007/bf02774212

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  19 in total

1.  T-cell dependence of immune response to hepatitis B antigen in mice.

Authors:  I M Roberts; C C Bernard; G N Vyas; I R Mackay
Journal:  Nature       Date:  1975-04-17       Impact factor: 49.962

2.  Activated human B cells display a functional IL 2 receptor.

Authors:  R Mittler; P Rao; G Olini; E Westberg; W Newman; M Hoffmann; G Goldstein
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

3.  Clones of alloreactive T cells.

Authors:  C G Fathman; H Hengartner
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

4.  Cellular immunity and hepatitis-associated, Australia antigen liver disease.

Authors:  F J Dudley; R A Fox; S Sherlock
Journal:  Lancet       Date:  1972-04-01       Impact factor: 79.321

5.  In vitro response to HBsAg of peripheral blood lymphocytes from recipients of hepatitis B vaccine.

Authors:  T W Chang; E Celis; R W Miller; V R Zurawski; P C Kung
Journal:  Hepatology       Date:  1984 Sep-Oct       Impact factor: 17.425

6.  Activities of lymphocytes mediating antibody-dependent cell-mediated cytotoxicity in patients with chronic active hepatitis.

Authors:  A Nonomura; G Ohta; K Kobayashi; Y Kato
Journal:  Tohoku J Exp Med       Date:  1981-09       Impact factor: 1.848

7.  Clones of human cytotoxic T lymphocytes derived from an allosensitized individual: HLA specificity and cell surface markers.

Authors:  B Malissen; T Kristensen; C Goridis; M Madsen; C Mawas
Journal:  Scand J Immunol       Date:  1981-09       Impact factor: 3.487

8.  In vitro influenza virus-specific antibody production in man: antigen-specific and HLA-restricted induction of helper activity mediated by cloned human T lymphocytes.

Authors:  J R Lamb; J N Woody; R J Hartzman; D D Eckels
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

9.  Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by a monoclonal B cell growth factor.

Authors:  A Muraguchi; J L Butler; J H Kehrl; A S Fauci
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

10.  Antigen-reactive T cell clones. I. Transcomplementing hybrid I-A-region gene products function effectively in antigen presentation.

Authors:  M Kimoto; C G Fathman
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more
  1 in total

1.  Production of lymphokines by HBsAg-reactive human T cell clones upon antigenic stimulation.

Authors:  A Nonomura; G Ohta
Journal:  Gastroenterol Jpn       Date:  1987-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.